EPL to be Active at the 36th American College of Toxicology (ACT) Annual Meeting
EPL is pleased to announce that we are a Platinum Level Sponsor of the American College of Toxicology (ACT) Annual Meeting in Summerlin, NV. EPL will be sponsoring the Opening Reception and will be exhibiting in Booth #308. EPL will also be sponsoring one Continuing Education Course and two Symposia during the meeting this year.
EPL is co-sponsoring a CE Course along with Biogen entitled, “Juvenile Toxicity Studies, Defining, and Overcoming the Challenges.” CE Course #3 will be held Sunday, November 8, 2015 from 8:00am – 11:30am. Dr. Tom Steinbach from EPL will be serving as Co-chair for this session which will focus on identifying and addressing challenges, particularly those associated with the species tested and those associated with histological evaluations of young animals.
Additional information about the CE Courses offered at the 2015 ACT Annual Meeting can be found at the ACT Annual Meeting website.
EPL is co-sponsoring a symposium along with Pre-Clinical Research Services entitled, “The First Cut is the Deepest: The History and Development of Safe Treatments for Wound Healing and Tissue Repair.” This session will be held on Tuesday, November 10, 2015 from 9:00am – 12:00pm. Dr. Kathleen Funk from EPL will be serving as Co-chair for Symposium #9 which will focus on how wounds were traditionally treated, what models and endpoints exist to study wound healing and the clinical relevance of such models. Toxicology and pathology endpoints and special considerations for appropriate treatment and assessment of wounds will also be discussed along with an overview of regulatory aspects of new pharmaceutical and medical device development, clinical aspects of treating small and large wounds and emerging therapies.
Dr. Paul Snyder from EPL will be serving as Chair for the Symposium, “Use of Genetically Modified or Surgically Adapted Animal Models of Human Disease in Non-clinical Drug Discovery and Development.” This session will be held on Wednesday, November 11, 2015 from 9:00am – 12:00pm. EPL will be co-sponsoring this symposium along with Eli Lilly and Company. Symposium #16 will provide an overview of commonly utilized animal models of human disease and their limitations in nonclinical safety testing including a lack of historical control, heterogeneity in disease expression, a limited life span, and confounding effects of the disease. This session will include recommendations for the use of animal models of human disease in drug discovery and safety assessment.
Additional information about the Symposia to be held at the 2015 ACT Annual Meeting can be found at the ACT Annual Meeting website.
For more information about all activities for the ACT 2015 Annual Meeting, please visit www.actox.org.